295: Humiras legacy, CEO symbolism, and genomic surgery
First, former Alnylam Pharmaceuticals CEO John Maraganore and STAT\u2019s Matthew Herper join us to discuss the legacy of AbbVie chief executive Richard Gonzalez, who announced his retirement this week. Then, we dive into the fascinating world of fetal genome surgery, as STAT\u2019s Megan Molteni joins us to explain the work of a scientist named Tippi MacKenzie.\nHere's where you can subscribe to our biotech newsletter, The Readout. And here's where you can subscribe to our newsletter on the business (and secretive inner workings) of the U.S. health care industry, Health Care Inc.